MedPath

The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy

Not Applicable
Completed
Conditions
Renal Neoplasm
Renal Injury
Interventions
Procedure: Remote Ischemic Preconditioning
Procedure: Sham control
Registration Number
NCT03273751
Lead Sponsor
Seoul National University Hospital
Brief Summary

This study is intended to evaluate the renal protective effect of Remote Ischemic Preconditioning (RIPC) in patients undergoing partial nephrectomy. Half of the enrolled subjects will receive 4 cycles of brief ischemia on the upper arm after anesthesia induction and prior to the surgery, while the other half will not receive this treatment as a control group.

Detailed Description

Remote Ischemic Preconditioning (RIPC) is the concept of mitigating ischemia-reperfusion injury to target organs by a brief episode of ischemia-reperfusion of the limb. The protective effect of RIPC on major organs has been demonstrated in an animal study, but its clinical efficacy has not yet been established.

The kidney is a typical organ vulnerable to ischemic injury, and the renal protective effect of RIPC can be expected. There have been many reports of renal protective effects of RIPC in cardiac and vascular surgery. On the other hand, few studies have investigated the effect of RIPC during partial nephrectomy in which ischemia-reperfusion injury can occur during the surgery.

In this study, the investigators will evaluate the effect of RIPC in patients undergoing partial nephrectomy to prevent renal impairment and improve the prognosis after the surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Adult patients scheduled to undergo open, laparoscopic, or robot-assisted laparoscopic partial nephrectomy
  • Normal contralateral renal function was defined as split renal function of >40% as determined by preoperative Tc-99m DiethyleneTriamine Pentaacetic Acid (DTPA) kidney scan
  • Written informed consent
Exclusion Criteria
  • Peripheral vascular disease involving upper extremities or lower extremities
  • Severe cardiopulmonary diseases (valvular or ischemic heart disease, heart failure, chronic obstructive pulmonary disease)
  • Hepatic failure, renal failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Remote Ischemic Preconditioning (RIPC)Remote Ischemic PreconditioningFour cycles of upper arm ischemia/reperfusion
Sham controlSham controlPlacement of a blood pressure cuff around upper arm without inflation.
Primary Outcome Measures
NameTimeMethod
Serum creatinine levelPostoperative day 1

Postoperative serum creatinine levels as an index of kidney damage

Secondary Outcome Measures
NameTimeMethod
The incidence of acute kidney injury (AKI)Within 7 days after surgery

The incidence of AKI according to the serum creatinine diagnostic criteria of Kidney Disease Improving Global outcomes (KDIGO) Clinical Practice Guideline for AKI

estimated glomerular filtration rate (eGFR)2 weeks after surgery

eGFR is obtained by the formula of Isotope Dilution Mass Spectrometry (IDMS) Modification of Diet in Renal Disease (MDRD).

Urine beta-2 microglobulin2 weeks after surgery

Urine beta-2 microglobulin

Serum creatinine level2 weeks after surgery

Postoperative serum creatinine levels as an index of kidney damage

Urine microalbumin2 weeks after surgery

Urine microalbumin

Regional oxygen saturation (rSO2) of the contralateral kidney of the operated side90 minutes after induction of anesthesia

Renal rSO2 of the contralateral kidney of the operated side is monitored with Near-infrared spectroscopy.

Urine creatinine level2 weeks after surgery

Urine creatinine level

Urine N-acetyl-beta-D-glucosaminidase2 weeks after surgery

Urine N-acetyl-beta-D-glucosaminidase

Glomerular filtration rate measured by scintigraphy12 months after surgery

Glomerular filtration rate measured by technetium diethylene triamine pentacetic acid (99mTc-DTPA) radionuclide scintigraphy

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath